Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with
BRCA1 or BRCA2 germline mutation
breast conserving surgery
locoregional recurrence
surgical decision
Journal
Breast cancer (Dove Medical Press)
ISSN: 1179-1314
Titre abrégé: Breast Cancer (Dove Med Press)
Pays: New Zealand
ID NLM: 101591856
Informations de publication
Date de publication:
2023
2023
Historique:
received:
18
11
2022
accepted:
08
02
2023
entrez:
28
2
2023
pubmed:
1
3
2023
medline:
1
3
2023
Statut:
epublish
Résumé
The optimal surgical therapy for newly diagnosed breast cancer with germline mutations in susceptibility genes is still uncertain for many physicians. In this study, we aimed to determine the efficacy of breast conserving surgery (BCS) in breast cancer patients with Seventy-five patients operated with BCS or mastectomy for breast cancer between 2006 and 2017 and had The median age of the patients was 42 years (20-77). Our findings indicate that BCS may serve as an efficacious alternative to mastectomy for breast cancer patients with
Sections du résumé
Background
UNASSIGNED
The optimal surgical therapy for newly diagnosed breast cancer with germline mutations in susceptibility genes is still uncertain for many physicians. In this study, we aimed to determine the efficacy of breast conserving surgery (BCS) in breast cancer patients with
Materials and Methods
UNASSIGNED
Seventy-five patients operated with BCS or mastectomy for breast cancer between 2006 and 2017 and had
Results
UNASSIGNED
The median age of the patients was 42 years (20-77).
Conclusion
UNASSIGNED
Our findings indicate that BCS may serve as an efficacious alternative to mastectomy for breast cancer patients with
Identifiants
pubmed: 36852260
doi: 10.2147/BCTT.S395054
pii: 395054
pmc: PMC9960707
doi:
Types de publication
Journal Article
Langues
eng
Pagination
163-173Informations de copyright
© 2023 Emiroglu et al.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to declare for this work.
Références
Ann Surg. 2014 Dec;260(6):1000-10
pubmed: 24950272
Clin Breast Cancer. 2020 Jun;20(3):e244-e250
pubmed: 32144082
Breast. 2021 Apr;56:26-34
pubmed: 33582622
J Clin Oncol. 2000 Oct 1;18(19):3360-9
pubmed: 11013276
J Natl Compr Canc Netw. 2022 Jun;20(6):691-722
pubmed: 35714673
BMJ. 2014 Feb 11;348:g226
pubmed: 24519767
Eur J Cancer. 2004 May;40(8):1150-8
pubmed: 15110878
Breast J. 2022 Dec 31;2022:1447545
pubmed: 36685664
Lancet. 1998 Jan 31;351(9099):316-21
pubmed: 9652611
Eur J Cancer Prev. 2021 Jul 1;30(4):311-314
pubmed: 32898012
Cancer. 2006 Jan 1;106(1):35-41
pubmed: 16333848
Gland Surg. 2020 Jun;9(3):775-787
pubmed: 32775268
J Am Coll Surg. 2006 Aug;203(2):198-207
pubmed: 16864033
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Breast Cancer. 2022 Mar;29(2):314-323
pubmed: 34766244
Cancers (Basel). 2022 Jul 01;14(13):
pubmed: 35805017
Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1014-21
pubmed: 18234444
Am J Surg. 2006 Jul;192(1):58-62
pubmed: 16769276
Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1332-1340
pubmed: 33259931
Breast Cancer Res Treat. 2014 Oct;147(3):571-8
pubmed: 25187270
J Clin Oncol. 2020 Jun 20;38(18):2080-2106
pubmed: 32243226
Breast Cancer Res Treat. 2017 Jun;163(3):565-571
pubmed: 28343309
Science. 1990 Dec 21;250(4988):1684-9
pubmed: 2270482
Breast Cancer Res. 2004;6(1):R8-R17
pubmed: 14680495
Ann Surg. 2019 Aug;270(2):364-372
pubmed: 29727326
Acta Oncol. 1999;38 Suppl 13:9-17
pubmed: 10612491